IL15 and COVID-19: Limitations of the study include: (1) the exclusion of HIV, HCV, or HBV seropositive individuals and COVID-19 patients with mild-to-moderate disease, which restricts our findings to a specific group of patients, and (2) the measurement of IL-15 serum levels may not be as easy in primary care.